- Home
- SRDX
SRDX
Surmodics Inc.
as 05-15-2025 10:44am EST
| Founded: | 1979 | Country: | United States |
| Employees: | N/A | City: | EDEN PRAIRIE |
| Market Cap: | N/A | IPO Year: | 1998 |
| Target Price: | $43.00 | AVG Volume (30 days): | 71.3K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.40 | EPS Growth: | N/A |
| 52 Week Low/High: | $26.00 - $42.44 | Next Earning Date: | 04-30-2025 |
| Revenue: | $121,575,000 | Revenue Growth: | -14.96% |
| Revenue Growth (this year): | 2.97% | Revenue Growth (next year): | 0.35% |
Latest Surmodics Inc. News
SRDX Breaking Stock News: Dive into SRDX Ticker-Specific Updates for Smart Investing
Zacks
13 days ago
Are Options Traders Betting on a Big Move in Surmodics Stock?
Zacks
14 days ago
SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts
Zacks
15 days ago
SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks
15 days ago
SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates
Associated Press Finance
15 days ago
SurModics: Fiscal Q2 Earnings Snapshot
Business Wire
15 days ago
Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
Business Wire
17 days ago
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
Business Wire
23 days ago
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
Compare SRDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRDX Surmodics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.